|
🐜
|
Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
9 auth.
U. Ladabaum,
Grace Wang,
J. Terdiman,
Amie M. Blanco,
M. Kuppermann,
C. Boland,
...
J. Ford,
E. Elkin,
K. Phillips
|
7 |
2011 |
7
🐜
|
|
🦁
|
Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling
Grace Wang,
M. Beattie,
N. Ponce,
K. Phillips
|
5 |
2011 |
5
🦁
|
|
🐬
|
Biomarker use in colorectal cancer therapy.
R. Kelley,
Grace Wang,
A. Venook
|
5 |
2011 |
5
🐬
|
|
🐜
|
Tradeoffs of Using Administrative Claims and Medical Records to Identify the Use of Personalized Medicine for Patients With Breast Cancer
7 auth.
S. Liang,
K. Phillips,
Grace Wang,
C. Keohane,
J. Armstrong,
William M. Morris,
...
J. Haas
|
4 |
2011 |
4
🐜
|
|
🦁
|
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
Grace Wang,
M. Kuppermann,
Benjamin Kim,
K. Phillips,
U. Ladabaum
|
4 |
2012 |
4
🦁
|
|
🐜
|
Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
8 auth.
M. Kuppermann,
Grace Wang,
Shirley Wong,
Amie M. Blanco,
P. Conrad,
S. Nakagawa,
...
J. Terdiman,
U. Ladabaum
|
4 |
2013 |
4
🐜
|
|
🐜
|
PI3K-AKT Signaling Is a Downstream Effector of Retinoid Prevention of Murine Basal Cell Carcinogenesis
7 auth.
P. So,
Grace Wang,
Kevin Wang,
Mindy Chuang,
V. Chiueh,
P. Kenny,
...
E. Epstein
|
3 |
2014 |
3
🐜
|
|
🦁
|
KRAS mutational analysis for colorectal cancer
Grace Wang,
R. Kelley,
GAPPNet
|
3 |
2010 |
3
🦁
|
